Back to results
CompletedPhase 2

Riluzole to Treat Parkinson's Disease

NCT00013624

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

National Institute of Neurological Disorders and Stroke (NINDS)

Bethesda, Maryland, United States

View on ClinicalTrials.gov
Riluzole to Treat Parkinson's Disease — TrialFind